InsiderTrades

Form 4 for QTTB Q32 Bio Inc.

Accepted 2024-03-27 00:00:00 ET · period of report 2024-03-25 · accession 0000950170-24-037197 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2024-03-27 2024-03-25 QTTB Alloway Paul See Remarks M - OptEx — +23.5K 51.6K +84% —
DM 2024-03-27 2024-03-25 QTTB Alloway Paul See Remarks M - OptEx $0.00 -23.5K 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-03-25 M A 23,530 — 51,566 D — — (F1) Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Issuer common stock.
2 Derivative Restricted Stock Units 2024-03-25 M D 5,440 $0.00 0 D — · — to — 5,440 Common Stock (F1) Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Issuer common stock. (F2) The vesting of these RSUs has been accelerated such that the RSUs vested in full on March 25, 2024, immediately prior to the Effective Time as defined in that certain Agreement and Plan of Merger by and among the Issuer, Kenobi Merger Sub, Inc. and Q32 Bio Inc. dated November 16, 2023.
3 Derivative Restricted Stock Units 2024-03-25 M D 18,090 $0.00 0 D — · — to — 18,090 Common Stock (F1) Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Issuer common stock. (F2) The vesting of these RSUs has been accelerated such that the RSUs vested in full on March 25, 2024, immediately prior to the Effective Time as defined in that certain Agreement and Plan of Merger by and among the Issuer, Kenobi Merger Sub, Inc. and Q32 Bio Inc. dated November 16, 2023.